pharmaphorum Podcast

pharmaphorum Podcast

Download on the App Store

pharmaphorum Podcast episodes

  • Understanding and addressing care disparities in rare cancers

    In today's podcast, sponsored by Oracle, host Jonah Comstock is joined by Otavio Clark, vice president of oncology at Cerner Enviza, an Oracle company, and Sheri McClerkin, an associate consultant in the Oncology & Specialty Therapeutics group at Cerner Enviza, to discuss the particular challenges of health inequity in the rare cancer space.

    47 min
  • Turning drug development on its head

    In this instalment of the pharmaphorum podcast, host Jonah Comstock welcomes Alchemab CEO Young Kwon, whose company has a different approach: starting with the healthiest of individuals and studying them to find out why they aren’t sick. Specifically, they’re looking through large data sets of healthy and disease-resistant people and looking for common antibodies that could help us all fight disease.

    27 min
  • Biopharma’s rapid transition to omnichannel marketing

    In today’s episode, sponsored by Veeva, we’ll hear a roundtable discussion on this fascinating topic featuring Victoria Serra Gittermann, European customer experience lead at Veeva Systems and Sebastian Noel, Veeva’s director of multichannel strategy – moderating a discussion with two executives with first-hand experience leading this change: Andy Eeckhout, global head of CRM and digital solutions at Advanz Pharma and Mokhtar Elsayed, head of global go to market commercial transformation at Sanofi.  

    1 hr 3 min
  • Partnering for holistic care

    In a new episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Eugene Borukhovich, co-founder and COO of YourCoach Health, and Lyndi Hirsch, SVP of marketing strategy at Medisafe. Both companies specialise in digital health and, although different, entered into a partnership at the end of June.

    38 min
  • Alzheimer’s drugs: An overview and update

    In the latest episode of the podcast, pharmaphorum Editor in Chief Jonah Comstock welcomes Dr. Alvaro Pascual-Leone, a neurology professor at Harvard Medical School, to the podcast to discuss how two new potentially groundbreaking Alzheimer's drugs work, describes the differences and similarities between them, and details both their exciting potential and their potential limitations. He also talks about the need for a holistic approach to Alzhemier’s treatment and the importance of lifestyle changes and early detection in fully addressing this devastating disease.  

     

    35 min
  • Collaborative perseverance to bring change to medicine access

    Recently, pharmaphorum web editor Nicole Raleigh spoke with Herbert Altmann, head of commercialisation and access solutions Europe at PharmaLex, and Casper Paardekooper, partner at Vintura. AmerisourceBergen completed the acquisition of PharmaLex (and Vintura, which was owned by PharmaLex).

    27 min

About pharmaphorum Podcast

From the publisher's feed

pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our…

More shows like pharmaphorum Podcast

Nature Podcast by Springer Nature Limited

Nature Podcast

764 Listeners

The Daily by The New York Times

The Daily

111,874 Listeners

The Readout Loud by STAT

The Readout Loud

334 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

35 Listeners

The Mel Robbins Podcast by Mel Robbins

The Mel Robbins Podcast

19,270 Listeners